Ind-Swift has reported results for the quarter and the year ended March 31, 2011.
The company’s net profit for the fourth quarter has increased by 5.38% at Rs 11.55 crore as compared to Rs 10.96 crore for the same quarter last year. Its income from operation has rose by 18.18% at Rs 236.20 crore for the quarter under review from Rs 199.86 crore in the corresponding previous quarter.
The company has registered growth of 14.95% in its net profit for the current year at Rs 42.21 crore as compared to Rs 36.72 crore for the previous year. Its income from operation has increased by 28.49% at Rs 875.61 crore for the year from Rs 681.45 crore in previous year.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1835.25 |
| Dr. Reddys Lab | 1306.55 |
| Cipla | 1362.95 |
| Zydus Lifesciences | 941.35 |
| Lupin | 2455.15 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: